JPWO2022024649A1 - - Google Patents
Info
- Publication number
- JPWO2022024649A1 JPWO2022024649A1 JP2022540096A JP2022540096A JPWO2022024649A1 JP WO2022024649 A1 JPWO2022024649 A1 JP WO2022024649A1 JP 2022540096 A JP2022540096 A JP 2022540096A JP 2022540096 A JP2022540096 A JP 2022540096A JP WO2022024649 A1 JPWO2022024649 A1 JP WO2022024649A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020128943 | 2020-07-30 | ||
PCT/JP2021/024778 WO2022024649A1 (ja) | 2020-07-30 | 2021-06-30 | 感冒剤及び抗ウイルス剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2022024649A1 true JPWO2022024649A1 (ja) | 2022-02-03 |
Family
ID=80035486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022540096A Pending JPWO2022024649A1 (ja) | 2020-07-30 | 2021-06-30 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20240041854A1 (ja) |
EP (1) | EP4190329A4 (ja) |
JP (1) | JPWO2022024649A1 (ja) |
KR (1) | KR20230044481A (ja) |
CN (1) | CN116249528A (ja) |
AR (1) | AR123100A1 (ja) |
AU (1) | AU2021315149A1 (ja) |
BR (1) | BR112023001266A2 (ja) |
CA (1) | CA3190455A1 (ja) |
TW (1) | TW202214593A (ja) |
WO (1) | WO2022024649A1 (ja) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2346507A1 (en) * | 2008-09-03 | 2011-07-27 | Boehringer Ingelheim International GmbH | Use of quinazoline derivatives for the treatment of viral diseases |
ES2587942T3 (es) * | 2009-02-04 | 2016-10-27 | Otsuka Pharmaceutical Factory, Inc. | Compuestos de fenilimidazol |
KR101317318B1 (ko) * | 2011-04-19 | 2013-10-14 | 원광대학교산학협력단 | 신종인플루엔자, 조류인플루엔자, 일반 및 독감감기, sars 바이러스 억제 효능을 갖는 오배자 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 약학 조성물 |
CN102797043B (zh) * | 2011-05-23 | 2015-11-25 | 天利康(天津)科技有限公司 | 药物分子片段库及其构建方法 |
JP6828899B2 (ja) | 2015-12-25 | 2021-02-10 | 株式会社大塚製薬工場 | フェニルイミダゾール化合物 |
-
2021
- 2021-06-30 JP JP2022540096A patent/JPWO2022024649A1/ja active Pending
- 2021-06-30 US US18/018,822 patent/US20240041854A1/en active Pending
- 2021-06-30 EP EP21850735.8A patent/EP4190329A4/en active Pending
- 2021-06-30 CN CN202180059358.XA patent/CN116249528A/zh active Pending
- 2021-06-30 BR BR112023001266A patent/BR112023001266A2/pt unknown
- 2021-06-30 AU AU2021315149A patent/AU2021315149A1/en active Pending
- 2021-06-30 CA CA3190455A patent/CA3190455A1/en active Pending
- 2021-06-30 KR KR1020237006842A patent/KR20230044481A/ko unknown
- 2021-06-30 WO PCT/JP2021/024778 patent/WO2022024649A1/ja active Application Filing
- 2021-07-09 TW TW110125322A patent/TW202214593A/zh unknown
- 2021-07-30 AR ARP210102133A patent/AR123100A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112023001266A2 (pt) | 2023-02-14 |
US20240041854A1 (en) | 2024-02-08 |
WO2022024649A1 (ja) | 2022-02-03 |
AU2021315149A1 (en) | 2023-03-02 |
EP4190329A4 (en) | 2024-07-31 |
AR123100A1 (es) | 2022-10-26 |
CA3190455A1 (en) | 2022-02-03 |
KR20230044481A (ko) | 2023-04-04 |
EP4190329A1 (en) | 2023-06-07 |
CN116249528A (zh) | 2023-06-09 |
TW202214593A (zh) | 2022-04-16 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240620 |